Ananda Centre for Cancer Research (ACCR) shared a post on LinkedIn:
“Presenting the Cancer Policy Lab Uganda (CPL-U) HPV Vaccination Policy Brief to Ministry of Health departments and development partners – a key step in translating evidence into policy action for cervical cancer prevention in Uganda.
Recently, we had the opportunity to present the inaugural Cancer Policy Lab Policy Brief on HPV Vaccination Prioritization in Uganda to Ministry of Health departments and development partners. The policy brief was very well received and generated a rich discussion on how Uganda can accelerate progress towards cervical cancer prevention through improved HPV vaccination coverage.
A key theme that emerged from the dialogue was the importance of sustainable domestic financing for HPV vaccination. Participants noted that current HPV vaccine procurement is largely supported through donor financing mechanisms, which operate within specific eligibility and implementation frameworks. There was broad agreement that strengthening domestic financing for vaccine procurement could create opportunities to expand access, improve programme sustainability, and accelerate progress towards national HPV vaccination goals.
Another important recommendation was to advance the policy brief to Parliament to stimulate broader discussions on sustainable financing for HPV vaccination and cancer prevention. Ministry officials welcomed continued engagement and committed to supporting linkages with relevant parliamentary stakeholders. The discussion reinforced the value of bringing together policymakers, researchers, clinicians, civil society organizations, and development partners to translate evidence into actionable policy recommendations.
The Cancer Policy Lab Uganda, an innovation of the Ananda Centre for Cancer Research (ACCR), was established to bridge the gap between evidence and policy through structured multi-sector dialogue and co-creation of practical policy solutions.
Thank you to all Ministry of Health departments, partners, and stakeholders who contributed to this important conversation.”
Learn more about the Cancer Policy Lab
Read our earlier post introducing the Cancer Policy Lab
Other articles about ACCR on OncoDaily.
